Sec Form 4 Filing - LARUE DAVID J @ Forest City Realty Trust, Inc. - 2017-09-14

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
LARUE DAVID J
2. Issuer Name and Ticker or Trading Symbol
Forest City Realty Trust, Inc. [ FCEA]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
CEO & President
(Last) (First) (Middle)
50 PUBLIC SQUARE, SUITE 1100
3. Date of Earliest Transaction (MM/DD/YY)
09/14/2017
(Street)
CLEVELAND, OH44113
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 14,559.601 I See footnote ( 1 )
Class A Common Stock 33,564.722 I See footnote ( 2 )
Class A Common Stock 16,450 D ( 3 )
Class A Common Stock 25,184 D ( 4 )
Class A Common Stock 32,209 D ( 5 )
Class A Common Stock 4,812.922 I See footnote ( 6 )
Class A Common Stock 4,812.922 I See footnote ( 7 )
Class A Common Stock 4,812.922 I See footnote ( 8 )
Class A Common Stock 09/14/2017 M 900 A $ 15.89 17,560 D ( 9 )
Class A Common Stock 09/15/2017 M 9,355 A $ 15.89 26,915 D ( 9 )
Class A Common Stock 09/14/2017 S 900 D $ 25.47 26,015 D ( 9 )
Class A Common Stock 09/15/2017 S 9,355 D $ 25.3203 ( 9 ) 16,660 D ( 9 )
Class A Common Stock 1,843.247 D ( 10 )
Class A Common Stock 6,835.374 I See footnote ( 11 )
Class A Common Stock 3,993.702 D ( 12 )
Class A Common Stock 211,102 D ( 13 )
Class A Common Stock 34,006.4465 I 401k Plan ( 14 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2008 Stock Option Grant (right to buy) $ 36.38 06/18/2010( 15 ) 06/18/2018 Class A Common 28,059 28,059 D ( 15 )
2010 Stock Option Grant (right to buy) $ 15.89 09/14/2017 M 900 04/14/2012( 16 ) 04/14/2020 Class A Common 900 $ 0 25,993 D ( 16 )
2010 Stock Option Grant (right to buy) $ 15.89 09/15/2017 M 9,355 04/14/2012( 16 ) 04/14/2020 Class A Common 9,355 $ 0 16,638 D ( 16 )
2011 Stock Option Grant (right to buy) $ 17.72 04/13/2013( 17 ) 04/13/2021 Class A Common 64,277 64,277 D ( 17 )
2012 Stock Option Grant (right to buy) $ 14.74 04/11/2014( 18 ) 04/11/2022 Class A Common 77,945 77,945 D ( 18 )
2013 Stock Option Grant (right to buy) $ 17.6 04/08/2015( 19 ) 04/08/2023 Class A Common 65,630 65,630 D ( 19 )
2014 Stock Option Grant (right to buy) $ 18.73 03/28/2016( 20 ) 03/28/2024 Class A Common 62,090 62,090 D ( 20 )
2014 Performance Shares $ 0 12/31/2017 08/08/1988( 21 ) Class A Common 38,441 38,441 D ( 21 )
2015 Performance Shares $ 0 12/31/2017 08/08/1988( 22 ) Class A Common 32,900 32,900 D ( 22 )
2016 Performance Shares $ 0 12/31/2018 08/08/1988( 23 ) Class A Common 50,367 50,367 D ( 23 )
2017 Performance Shares $ 0 12/31/2019 08/08/1988( 24 ) Class A Common 48,313 48,313 D ( 24 )
2015 Out Performance Shares $ 0 12/31/2017 08/08/1988( 25 ) Class A Common 50,000 50,000 D ( 25 )
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
LARUE DAVID J
50 PUBLIC SQUARE, SUITE 1100
CLEVELAND, OH44113
X CEO & President
Signatures
J. Matthew Shady, Attorney-In-Fact for David J. LaRue 09/18/2017
Signature of Reporting Person Date
Explanation of Responses:
( 1 )David J. LaRue Trust.
( 2 )David LaRue Family Trust
( 3 )2015 Restricted Stock Grant - 25% vest on 3/26/2016; 25% vest on 3/26/2017; and 50% vest on 3/26/2018.
( 4 )2016 Restricted Stock Grant - 25% vest on 3/23/2017; 25% vest on 3/23/2018; and 50% vest on 3/23/2019.
( 5 )2017 Restricted Stock Grant - 25% vest on 3/24/2018; 25% vest on 3/24/2019; and 50% vest on 3/24/2020.
( 6 )Shares held by Andre LaRue, son, Cindy LaRue (spouse) is custodian on the account - Indirect
( 7 )Shares held by Paul LaRue, son, Cindy LaRue (spouse) is custodian on the account - Indirect
( 8 )Shares held by Tessa LaRue, daughter,
( 9 )Shares are held in street account with Charles Schwab. 9/15/2017: The price $25.3203 represents a weighted average of sales prices ranging from $25.3200 per share to $25.3250 per share. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a security holder of the issuer upon request.
( 10 )Shares held by David LaRue - Roth IRA
( 11 )Shares are held by Cindy LaRue (spouse) in street account.
( 12 )Shares are held by David LaRue & Cindy LaRue Trust account.
( 13 )Shares are held by transfer agent in a direct registration account.
( 14 )FCE's 401k Plan account, shares are held indirect.
( 15 )2008 Stock Option Grant - 25% exercisable 6/18/2010; 25% exercisable 6/18/2011; and 50% exercisable 6/18/2012.
( 16 )2010 Stock Option Grant - 25% exercisable 4/14/2012; 25% exercisable 4/14/2013; and 50% exercisable 4/14/2014.
( 17 )2011 Stock Option Grant - 25% exercisable 4/13/2013; 25% exercisable 4/13/2014; and 50% exercisable 4/13/2015.
( 18 )2012 Stock Option Grant - 25% exercisable 4/11/2014; 25% exercisable 4/11/2015; and 50% exercisable 4/11/2016.
( 19 )2013 Stock Option Grant - 25% exercisable 4/08/2015; 25% exercisable 4/08/2016; and 50% exercisable 4/08/2017.
( 20 )2014 Stock Option Grant - 0% exercisable 3/28/2015; 25% exercisable 3/28/2016; 25% exercisable 3/28/2017; and 50% exercisable 3/28/2018.
( 21 )Performance Shares Award - granted 3/28/2014 - performance period is from January 1, 2014 to December 31, 2017. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $18.73 per share. There is no fixed expiration date.
( 22 )Performance Shares Award - granted 3/26/2015 - performance period is from January 1, 2015 to December 31, 2017. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $24.62 per share. There is no fixed expiration date.
( 23 )Performance Shares Award - granted 3/23/2016 - performance period is from January 1, 2016 to December 31, 2018. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $20.94 per share. There is no fixed expiration date.
( 24 )Performance Shares Award - granted 3/24/2017 - performance period is from January 1, 2017 to December 31, 2019. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $21.83 per share. There is no fixed expiration date.
( 25 )Out Performance Shares Award - granted 3/27/2015 - performance period is from January 1, 2015 to December 31, 2017. Awards will vest 50% on December 31, 2017 and 50% on December 31, 2018 and will be available to the grantee provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 300% of the number of Performance Shares granted. Fair market value on date of grant is $25.31 per share. There is no fixed expiration date.

Remarks:
Accounts with automatic dividend reinvestment have been updated to reflect current balances.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.